Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Why do oral dosage forms support scale and access
In vivo CRISPR-Cas9 inhibition of hepatic LDH as treatment of primary hyperoxaluria
The use of FDA-approved excipients and innovative formulation platforms has been explored to optimize the properties and permeation behaviour of drugs in the skin [180]
Tissue repair pathways documented in animal wound-healing models
US$ 26.88
US$ 23.46
US$ 29.15
US$ 21.81
US$ 25.72
US$ 29.26
US$ 20.19
US$ 26.21
